A phase I/II study of low-dose of nedaplatin (CDGP) and 5-FU [fluorouracil] combined with radiation for the treatment of esophageal cancer

Trial Profile

A phase I/II study of low-dose of nedaplatin (CDGP) and 5-FU [fluorouracil] combined with radiation for the treatment of esophageal cancer

Completed
Phase of Trial: Phase I/II

Latest Information Update: 24 Mar 2009

At a glance

  • Drugs Fluorouracil (Primary) ; Nedaplatin (Primary)
  • Indications Oesophageal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 19 Feb 2009 Official Title amended as reported by ClinicalTrials.gov.
    • 19 Feb 2009 Patient numbers amended from 40 to 33 as reported by ClinicalTrials.gov.
    • 19 Feb 2009 End date added from CliniclTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top